BioCentury
ARTICLE | Company News

Immunomedics diagnostics/imaging, cancer news

July 15, 1996 7:00 AM UTC

IMMU completed construction of a 7,500-square foot manufacturing facility at its Morris Plains, N.J., headquarters. The facility will be used to manufacture IMMU's CEA-Scan (arcitumomab), which has b...